Liposomal supplement brand scaling D2C through social and subscription
Cymbiotika manufactures liposomal supplements and sells direct-to-consumer via social commerce. The hiring mix—three marketing roles against one ops and one support—reflects a growth-stage D2C playbook: audience acquisition and content velocity outpace internal ops scaling. Active projects center on Klaviyo lifecycle optimization and subscription programs, while pain points (inventory discrepancies, 3PL management, scaling social presence) signal operational friction typical of brands moving from launch into sustained growth.
Cymbiotika manufactures and sells liposomal supplements through direct-to-consumer channels. Founded in 2018 and based in San Diego, the company operates as a privately held firm with 51–200 employees. The product line focuses on liposomal delivery technology, marketed primarily through social platforms (Instagram, TikTok, YouTube, Pinterest) and managed via Klaviyo email and SMS. Operations run on NetSuite (ERP) and a warehouse management system, with fulfillment through third-party logistics partners. Current focus includes subscription and loyalty program expansion, social media content strategy, and resolving inventory and 3PL coordination challenges.
Cymbiotika uses Klaviyo for email/SMS, NetSuite for ERP, a WMS for inventory, and Meta/Instagram/TikTok/YouTube/Pinterest for social commerce. Excel is also in active use.
Cymbiotika is headquartered in San Diego, California. The company was founded in 2018 and remains privately held with 51–200 employees.
Other companies in the same industry, closest in size